CINECA IRIS Institutional Research Information System

BARUTELLO, GIUSEPPINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.913
EU - Europa 904
AS - Asia 653
SA - Sud America 14
OC - Oceania 8
AF - Africa 7
Totale 3.499
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.874
IT - Italia 385
CN - Cina 303
SG - Singapore 151
IE - Irlanda 109
SE - Svezia 96
FR - Francia 66
VN - Vietnam 48
DE - Germania 43
PL - Polonia 38
GB - Regno Unito 34
JP - Giappone 33
CA - Canada 32
UA - Ucraina 27
ID - Indonesia 24
HK - Hong Kong 23
KR - Corea 22
FI - Finlandia 21
IN - India 21
NO - Norvegia 15
AT - Austria 10
TW - Taiwan 10
BE - Belgio 9
GR - Grecia 9
NL - Olanda 8
PT - Portogallo 8
AU - Australia 7
BR - Brasile 7
CH - Svizzera 6
CU - Cuba 6
PH - Filippine 5
AR - Argentina 4
ES - Italia 4
RU - Federazione Russa 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
NG - Nigeria 3
SN - Senegal 3
SI - Slovenia 2
SY - Repubblica araba siriana 2
TR - Turchia 2
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
MC - Monaco 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
Totale 3.499
Salva come PNG Salva come JPEG
Città #
Chandler 260
Fairfield 192
Houston 138
Singapore 109
Ashburn 108
Dublin 108
Torino 88
Woodbridge 87
Beijing 85
Seattle 79
Wilmington 78
Cambridge 72
Turin 58
Ann Arbor 52
Pisa 46
Redwood City 46
Nyköping 43
Santa Clara 43
Jacksonville 36
Warsaw 31
Villeurbanne 30
Medford 28
Shanghai 28
Princeton 26
Columbus 24
Dearborn 24
Jakarta 24
Nanjing 20
Fremont 19
Dong Ket 18
Hangzhou 16
San Diego 15
Milan 14
Guangzhou 13
New York 13
Villa Bartolomea 13
Oslo 12
Ottawa 12
Boston 11
Hong Kong 10
Toronto 9
Athens 8
Phoenix 8
Taipei 8
Zhengzhou 8
Boardman 7
Chennai 7
Munich 7
Paris 7
Tianjin 7
Tokyo 7
Vigliano Biellese 7
Washington 7
Wuhan 7
Xian 7
Changsha 6
Hyderabad 6
La Habana 6
Padova 6
Parma 6
Rome 6
Silver Spring 6
Vienna 6
Chengdu 5
Falls Church 5
Fuzhou 5
Hebei 5
London 5
Los Angeles 5
Seoul 5
Birmingham 4
Brussels 4
Central District 4
Federal 4
Gent 4
San Jose 4
Tamworth 4
Upper Marlboro 4
Utrecht 4
Bologna 3
Buffalo 3
Dresden 3
Frankfurt am Main 3
Hefei 3
Helsinki 3
Nanning 3
Norwalk 3
Olney 3
Rio de Mouro 3
Würzburg 3
Zurich 3
Abuja 2
Apex 2
Bangalore 2
Barcelona 2
Bethesda 2
Bothell 2
Centro 2
Changchun 2
Cincinnati 2
Totale 2.413
Salva come PNG Salva come JPEG
Nome #
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 439
CSPG4: a prototype oncoantigen for translational immunotherapy studies 266
Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy 240
DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesis 202
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 198
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivo 169
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice 166
Angiomotin like-1 is a novel component of the N-cadherin complex affecting endothelial/pericyte interaction in normal and tumor angiogenesis 163
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 160
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model 152
Maternal immunization: New perspectives on its application against non-infectious related diseases in newborns 145
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice 141
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 126
Strengths and weaknesses of pre-clinical models for human melanoma treatment: Dawn of dogs’ revolution for immunotherapy 120
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 101
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 98
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies 95
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 93
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 81
Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy 78
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 71
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 64
On the Fate of MRI Gd-Based Contrast Agents in Cells. Evidence for Extensive Degradation of Linear Complexes upon Endosomal Internalization 59
Teneurins: Role in Cancer and Potential Role as Diagnostic Biomarkers and Targets for Therapy 59
The Amot/integrin protein complex transmits mechanical forces required for vascular expansion 51
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer Models 27
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source 21
Totale 3.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.946
article - articoli 0
book - libri 0
conference - conferenze 243
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.189
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020457 0 0 0 0 35 89 66 60 69 66 35 37
2020/2021574 24 40 38 33 45 37 43 39 77 70 39 89
2021/2022522 32 21 30 36 30 24 37 31 29 58 124 70
2022/2023721 63 53 17 64 71 167 59 52 89 12 40 34
2023/2024354 44 33 32 20 12 51 57 20 5 24 23 33
2024/2025272 10 53 39 71 99 0 0 0 0 0 0 0
Totale 3.585